Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19.
COVID-19
SARS-CoV-2
biomarker
infection
severity
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
07
2020
accepted:
08
09
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
13
11
2020
Statut:
epublish
Résumé
Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.
Identifiants
pubmed: 33178720
doi: 10.3389/fmed.2020.580677
pmc: PMC7592395
doi:
Types de publication
Journal Article
Langues
eng
Pagination
580677Informations de copyright
Copyright © 2020 Alberca, Andrade, Branco, Pietrobon, Pereira, Fernandes, Oliveira, Teixeira, Beserra, Oliveira, Gozzi-Silva, Ramos, de Brito, Arnone, Orfali, Aoki, Duarte and Sato.
Références
J Infect. 2020 Jul;81(1):e6-e12
pubmed: 32283162
Front Immunol. 2020 Jul 07;11:1672
pubmed: 32733490
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
Nat Rev Cancer. 2013 Oct;13(10):739-52
pubmed: 24060865
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Front Med (Lausanne). 2020 Apr 30;7:190
pubmed: 32426363
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Front Mol Biosci. 2020 Jul 03;7:157
pubmed: 32719810
J Immunother Cancer. 2019 Aug 28;7(1):230
pubmed: 31462270
Cell Death Differ. 2020 Nov;27(11):3196-3207
pubmed: 32514047
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4
pubmed: 32425269
Front Immunol. 2020 Jan 31;11:90
pubmed: 32082331
Crit Rev Food Sci Nutr. 2020 Jun 15;:1-15
pubmed: 32539446
Front Med (Lausanne). 2020 Jun 11;7:295
pubmed: 32596248
Trends Immunol. 2011 Jan;32(1):19-25
pubmed: 21067974